Mitotic kinesin inhibitors
CA 2467726 A1 · Owner: Hartman, George D. · Inventors: Hartman, George D.; Fraley, Mark E.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The present invention relates to furanopyrimidinone compounds that are useful for treating cellular proliferative diseases for treating disorders , associated with KSP kinesin activity and for inhibiting KSP kinesin. The , invention also related to compositions which comprise these compounds and , methods of using them to treat cancer in mammals.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed December 2, 2002. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended December 2, 2022.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by December 2, 2024.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.